Article info
PDFCommentary
Primary care
Rivaroxaban plus aspirin, compared with aspirin alone, reduced cardiovascular events in patients with stable peripheral or carotid artery disease, but increased the risk of major bleeding
- Correspondence to Professor Jonathan Mant, Primary Care Unit, Strangeways Research Laboratory, University of Cambridge, CB1 8RN; jm677{at}medschl.cam.ac.uk
Citation
Rivaroxaban plus aspirin, compared with aspirin alone, reduced cardiovascular events in patients with stable peripheral or carotid artery disease, but increased the risk of major bleeding
Publication history
- Accepted March 2, 2018
- First published April 12, 2018.
Online issue publication
April 09, 2020
Article Versions
- Previous version (9 April 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.